Drug intelligence / Profile preview

piceid + resveratrol

Development stage
Unknown
Lead developer
Revgenetics
Modality
Small Molecules
Administration
Oral
01

Overview

Piceid + resveratrol is a combination of two related stilbenoid polyphenols. Piceid, also known as polydatin, is the 3-beta-D-glucoside of resveratrol and serves as its primary natural precursor. While piceid is often converted to resveratrol in the gastrointestinal tract via glycosidases, it also exhibits distinct pharmacokinetic properties, including potentially higher oral bioavailability due to active transport mechanisms. Together, these compounds act as potent antioxidants and anti-inflammatory agents. Their primary mechanism of action involves the activation of Sirtuin 1 (SIRT1), a NAD+-dependent deacetylase associated with longevity and metabolic regulation, and the inhibition of pro-inflammatory pathways such as NF-kappaB and cyclooxygenase (COX) enzymes. This combination is frequently utilized in dietary supplements derived from *Polygonum cuspidatum* (Japanese Knotweed) for indications including cardiovascular health, metabolic syndrome, and neuroprotection.

Brand names
Resverasol
Other names
polydatin + resveratrol3,5,4'-trihydroxystilbene-3-O-beta-D-glucoside + 3,5,4'-trihydroxystilbene
02

Targets

NF-κBSIRT1 (NAD-dependent protein deacetylase sirtuin-1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on piceid + resveratrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on piceid + resveratrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call